Early research (Phase 1)WithdrawnNCT03231475What this trial is testingPhase I Study of SPH1188-11 in NSCLCWho this might be right forNSCLC Stage IIIBNSCLC Stage IV Shanghai Pharmaceuticals Holding Co., Ltd
Not applicableNot Yet RecruitingNCT07256457What this trial is testingPostoperative Pulmonary Function Assessment Based on Deep Learning StudyWho this might be right forLung Cancer (NSCLC) Chinese University of Hong Kong 192
Large-scale testing (Phase 3)WithdrawnNCT04203511What this trial is testingINCMGA00012 in Combination With Chemoradiation in Participants With Stage III Non-Small Cell Lung Cancer (POD1UM-301)Who this might be right forNon-small Cell Lung Cancer Incyte Corporation
Large-scale testing (Phase 3)Study completedNCT01207011What this trial is testingAmrubicin (AMR) Trial in Patients With Non-small Cell Lung CancerWho this might be right forLung Cancer Sumitomo Pharma Co., Ltd. 202
Testing effectiveness (Phase 2)Study completedNCT01935336What this trial is testingStudy of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive BiomarkersWho this might be right forAdenocarcinoma of the LungExtensive Stage Small Cell Lung CancerLimited Stage Small Cell Lung Cancer+5 more University of Colorado, Denver 171
Early research (Phase 1)Active Not RecruitingNCT04197934What this trial is testingWSD0922-FU for Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System MetastasesWho this might be right forAnaplastic Astrocytoma, IDH-WildtypeGlioblastoma, IDH-WildtypeMetastatic Lung Non-Small Cell Carcinoma+2 more Mayo Clinic 56
Early research (Phase 1)Not Yet RecruitingNCT07798921What this trial is testingJIN-A02 Plus Amivantamab in EGFR-Mutant NSCLC After Third-Generation EGFR-TKI FailureWho this might be right forCarcinomaNon-Small-Cell Lung Yonsei University 36
Not applicableStudy completedNCT02717221What this trial is testingIn Vivo EGFR Molecular Classification and Treatment ResponseWho this might be right forMolecular Imaging Harbin Medical University 102
Testing effectiveness (Phase 2)Study completedNCT02976116What this trial is testingA Phase II Study of Fruquintinib in Combination With Gefitinib in Patients With Advanced Non-small Cell Lung CancerWho this might be right forNSCLC Hutchison Medipharma Limited 50
Early research (Phase 1)Ended earlyNCT01565772What this trial is testingProton Radiation Therapy With Cisplatin and Etoposide Followed by Surgery in Stage III Non-Small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer Massachusetts General Hospital 4
Not applicableStudy completedNCT04887519What this trial is testingBrigatinib to Treat Adults With Anaplastic Lymphoma Kinase (ALK) Positive Metastatic Non Small Cell Lung Cancer (NSCLC)Who this might be right forCarcinoma, Non-Small-Cell LungAnaplastic Lymphoma Kinase Takeda 39
Testing effectiveness (Phase 2)Study completedNCT00529100What this trial is testingConcurrent Pemetrexed, Cisplatin and Radiation Therapy in Patients With Stage IIIA/B Non Small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer Eli Lilly and Company 49
Early research (Phase 1)Study completedNCT03810807What this trial is testingStudy of Dacomitinib and Osimertinib for Patients With Advanced EGFR Mutant Lung CancerWho this might be right forMetastatic Non-small Cell Lung Cancer Memorial Sloan Kettering Cancer Center 22
Testing effectiveness (Phase 2)Study completedNCT00518011What this trial is testingTarceva (Erlotinib) and Gemcitabine in Treatment-Naive Patients With Advanced Non-Small Cell Lung Cancer.Who this might be right forNon-Squamous Non-Small Cell Lung Cancer Hoffmann-La Roche 17
Early research (Phase 1)Study completedNCT01199055What this trial is testingCS-7017 in Combination With Carboplatin/Paclitaxel in Subjects With Stage IIIb/IV Non-small Cell Lung Cancer (NSCLC)Who this might be right forCarcinoma, Non-Small-Cell Lung Daiichi Sankyo Co., Ltd. 16
Testing effectiveness (Phase 2)Study completedNCT00077415What this trial is testing3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung CancerWho this might be right forLung Cancer Cancer Therapeutics Research Group 31
Early research (Phase 1)Not Yet RecruitingNCT06015568What this trial is testingStudy of MCLA-129 Combined With Befotertinib in the Treatment of Advanced Non-small Cell Lung Cancer With EGFR Sensitive MutationWho this might be right forNon-Small Cell Lung Cancer、EGFR Sensitive Mutation Betta Pharmaceuticals Co., Ltd. 172
Testing effectiveness (Phase 2)Study completedNCT00050674What this trial is testingDocetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung CarcinomaWho this might be right forNon-small Cell Lung Cancer Schwartzberg, Lee, M.D. 40
Not applicableStudy completedNCT02730897What this trial is testingMulticentric Analysis of Predictors of N1 Upstaging After Resection of cStage-I NSCLCWho this might be right forNon Small Cell Lung Cancer University Hospital, Gasthuisberg 956
Early research (Phase 1)Study completedNCT02503358What this trial is testingSelumetinib and Paclitaxel as Second-Line Treatment in Treating Patients With Stage IIIB-IV Non-small Cell Lung CancerWho this might be right forStage IIIB Non-Small Cell Lung Cancer AJCC v7Stage IV Non-Small Cell Lung Cancer AJCC v7 OHSU Knight Cancer Institute 23